A new preclinical study by Mass Eye and Ear investigators showed that a novel mRNA-based therapy may be able to prevent blindness and scarring from proliferative vitreoretinopathy (PVR) following a ...
Encinitas, California--(Newsfile Corp. - May 5, 2025) - Kiora Pharmaceuticals, Inc. (KPRX) (NASDAQ: KPRX), ("Kiora" or the "Company") today announced the results from a preclinical study demonstrating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results